Terug
Dagbereik
€ 7,40
€ 7,91
52-Weeksbereik
€ 2,83
€ 11,50
Volume
1.200.726
50D / 200D Gem.
€ 8,62
/
€ 7,49
Vorige Slotkoers
€ 7,61
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -8,5 | 0,4 |
| P/B | 2,7 | 2,9 |
| ROE % | -35,0 | 3,7 |
| Net Margin % | — | 3,9 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 11,25
+44.6%
Low: € 10,00
High: € 13,00
Forward WPA
-€ 1,08
Omzet Sch.
79 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
-€ 0,02
-€ 0,02 – -€ 0,02
|
220 M | 1 |
| FY2029 |
-€ 0,13
-€ 0,14 – -€ 0,12
|
180 M | 1 |
| FY2028 |
-€ 0,53
-€ 0,55 – -€ 0,51
|
160 M | 2 |
Belangrijkste Punten
Debt/Equity of 0,12 — conservative balance sheet
Negative free cash flow of -79,45M
PEG of 0,26 suggests growth is underpriced
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)-100,00%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-35,02%
ROIC-22,54%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,12
Current Ratio6,76
Interest Coverage-429,55
Waardering
P/E Ratio
-8,50
P/B Ratio2,65
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -100,00% | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -81,27M |
| ROE | -35,02% | ROA | -24,32% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -79,45M |
| ROIC | -22,54% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,12 | Current Ratio | 6,76 |
| Interest Coverage | -429,55 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -8,50 | P/B Ratio | 2,65 |
| P/S Ratio | N/A | PEG Ratio | 0,26 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 690,90M | Enterprise Value | 598,52M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 84,61M | 73,48M | 65,05M | 85,49M |
| Net Income | -81,27M | -81,28M | -108,30M | -113,32M | -65,23M |
| EPS (Diluted) | -0,91 | -1,37 | -2,25 | -2,48 | -1,49 |
| Gross Profit | -53,87M | 26,83M | 18,21M | 13,35M | 31,66M |
| Operating Income | -88,06M | -68,27M | -109,94M | -115,53M | -65,35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 334,16M | 270,27M | 225,10M | 292,70M | 396,53M |
| Total Liabilities | 72,98M | 67,31M | 95,66M | 74,56M | 86,23M |
| Shareholders' Equity | 261,19M | 202,96M | 129,44M | 218,14M | 310,30M |
| Total Debt | 31,87M | 44,25M | 47,73M | 48,65M | 58,33M |
| Cash & Equivalents | 124,25M | 91,42M | 56,98M | 89,13M | 105,59M |
| Current Assets | 267,95M | 203,02M | 146,74M | 199,70M | 318,23M |
| Current Liabilities | 39,63M | 31,13M | 47,23M | 33,13M | 31,31M |